2022-07-05-世界卫生组织-Immunization_Egypt_2022_country_profile_18页_369kb

报告摘要

Summary of WHO and UNICEF Immunization Coverage Estimates for Egypt (2021 Revision)

Purpose: Provision of country-specific immunization coverage estimates by WHO and UNICEF for Egypt, based on empirical data, surveys, and national reports.
Timeframe: Data received as of July 7, 2022, covering years from 2010 to 2021, with the 2021 revision reflecting up-to-date assessments.
Methodology: Estimates are derived from national government reports, household surveys (e.g., Egypt Demographic and Health Surveys), and demographic data; confidence levels (GoC) indicate empirical support without classical uncertainty measures.
Key Vaccines Covered: BCG (birth dose), DTP1 (first dose), DTP3 (third dose), Pol3 (third polio dose), IPV1 (at least one inactivated polio dose), MCV1 (first measles dose), MCV2 (second measles dose), RCV1 (first rubella dose), HepBB (hepatitis B birth dose), HepB3 (third hepatitis B dose), Hib3 (third Hib dose), RotaC (final rotavirus dose), PcV3 (third pneumococcal dose), YFV (yellow fever dose).
Coverage Trends: High overall coverage in 2010-2019, with declines noted in 2020-2021 for many vaccines (e.g., DTP3 around 95-97%, Pol3 around 95-96%); no coverage estimates for newer vaccines like RotaC and PcV3 in early years. Underestimation risk due to late data reporting.
Confidence Levels: Most estimates are well-supported (GoC •••) based on multiple data sources, but surveys are rare, reducing confidence in years without support.
Disclaimer: Estimates should be used with caution due to varying data quality and the absence of probability models, as national data trends may not fully capture system performance.